huntingtin < huntington < hybrid

Facettes :

List of bibliographic references indexed by huntington

Number of relevant bibliographic references: 313.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000025 (2015)	Kathleen M. Shannon [États-Unis] ; Avram Fraint [États-Unis]	Therapeutic advances in Huntington's Disease.
000051 (2015)	Shafik N. Wassef [États-Unis] ; John Wemmie [États-Unis] ; Casey P. Johnson [États-Unis] ; Hans Johnson [États-Unis] ; Jane S. Paulsen [États-Unis] ; Jeffrey D. Long [États-Unis] ; Vincent A. Magnotta [États-Unis]	T1ρ imaging in premanifest Huntington disease reveals changes associated with disease progression.
000059 (2015)	Andrew G. Hoss [États-Unis] ; Valentina N. Lagomarsino [États-Unis] ; Samuel Frank [États-Unis] ; Tiffany C. Hadzi [États-Unis] ; Richard H. Myers [États-Unis] ; Jeanne C. Latourelle [États-Unis]	Study of plasma-derived miRNAs mimic differences in Huntington's disease brain.
000078 (2015)	Calum D. Moulton [Royaume-Uni] ; C W P. Hopkins [Royaume-Uni] ; W Richard Bevan-Jones [Royaume-Uni]	Reply: Suicidality in Huntington's Disease: Distinguishing lithium from other psychotropic medications.
000115 (2015)	Roger L. Albin [États-Unis] ; James F. Burke [États-Unis]	Potential trade-offs in treatment of premanifest Huntington's disease.
000163 (2015)	Jeffrey D. Long [États-Unis] ; Jane S. Paulsen [États-Unis]	Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD.
000189 (2015)	Michele Raja [Italie] ; Francesco Soleti [Italie] ; Anna Rita Bentivoglio [Italie]	Lithium Treatment in Patients With Huntington's Disease and Suicidal Behavior.
000239 (2015)	Maria Dale [Royaume-Uni] ; John Maltby [Royaume-Uni] ; Rossana Martucci [Royaume-Uni] ; Steve Shimozaki [Royaume-Uni]	Factor analysis of the hospital anxiety and depression scale among a Huntington's disease population.
000243 (2015)	Joaquim J. Ferreira [Portugal] ; Anne Rosser [Royaume-Uni] ; David Craufurd [Royaume-Uni] ; Ferdinando Squitieri [Italie] ; Nicholas Mallard [États-Unis] ; Bernhard Landwehrmeyer [Allemagne]	Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trial.
000341 (2015)	Ralf Reilmann [Allemagne] ; Marie-Laure Rouzade-Dominguez ; Carsten Saft ; Sigurd D. Süssmuth ; Josef Priller ; Anne Rosser ; Hugh Rickards ; Ludger Schöls ; Nicole Pezous ; Fabrizio Gasparini ; Donald Johns ; Georg Bernhard Landwehrmeyer ; Baltazar Gomez-Mancilla	A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease.
000345 (2015)	Adriana Prundean [France] ; Katia Youssov ; Sandrine Humbert ; Dominique Bonneau ; Christophe Verny	A phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease.
000351 (2015)	Aaron Sturrock [Canada] ; Corree Laule ; Katy Wyper ; Ruth A. Milner ; Joji Decolongon ; Rachelle Dar Santos ; Allison J. Coleman ; Kimberley Carter ; Susan Creighton ; Natalie Bechtel ; Stefan Bohlen ; Ralf Reilmann ; Hans J. Johnson ; Michael R. Hayden ; Sarah J. Tabrizi ; Alex L. Mackay ; Blair R. Leavitt	A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers.
000366 (2014)	Ashwini K. Rao ; Karen S. Marder ; Jasim Uddin ; Brian C. Rakitin	Variability in interval production is due to timing dependent deficits in Huntington’s disease
000393 (2014)	Marina Papoutsi [Royaume-Uni] ; Izelle Labuschagne ; Sarah J. Tabrizi ; Julie C. Stout	The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation.
000399 (2014)	Anne-Wil Heemskerk [Pays-Bas] ; Berit M. Verbist ; Johan Marinus ; Bas Heijnen ; Elisabeth V. Sjögren ; Raymund A C. Roos	The Huntington's Disease Dysphagia Scale.
000406 (2014)	Edward J. Wild ; Sarah J. Tabrizi	Targets for future clinical trials in Huntington's disease: What's in the pipeline?
000409 (2014)	Calum D. Moulton ; C W P. Hopkins ; W Richard Bevan-Jones	Systematic review of pharmacological treatments for depressive symptoms in Huntington's disease.
000459 (2014)	Abhishek Chandra ; Ashu Johri ; M. Flint Beal	Prospects for Neuroprotective Therapies in Prodromal Huntington's disease
000463 (2014)	Rainer Hoffmann [Allemagne] ; Sven H. Stüwe ; Oliver Goetze ; Matthias Banasch ; Peter Klotz ; Carsten Lukas ; Martin Tegenthoff ; Christian Beste ; Michael Orth ; Carsten Saft	Progressive hepatic mitochondrial dysfunction in premanifest Huntington's disease.
000474 (2014)	Eirini Kalliolia [Royaume-Uni] ; Edina Silajdži ; Rajasree Nambron ; Nathan R. Hill ; Anisha Doshi ; Chris Frost ; Hilary Watt ; Peter Hindmarsh ; Maria Björkqvist ; Thomas T. Warner	Plasma melatonin is reduced in Huntington's disease.
000490 (2014)	Jane S. Paulsen [États-Unis] ; Jeffrey D. Long [États-Unis]	Onset of Huntington disease: Can it be purely cognitive?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "huntington" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "huntington" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    huntington
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024